2012
DOI: 10.1021/bc300407x
|View full text |Cite
|
Sign up to set email alerts
|

Functionalization of Microstructured Open-Porous Bioceramic Scaffolds with Human Fetal Bone Cells

Abstract: Bone substitute materials permissive for trans-scaffold migration and in-scaffold survival of human bone-derived cells are mandatory to develop cell-engineered permanent implants to repair bone defects. In this study, we evaluated the influence on human bone-derived cells of the material composition and microstructure of foam scaffolds made from calcium aluminate using a direct foaming method allowing wide-range tailoring of the microstructure for pore size and pore openings. Human fetal osteoblasts attached t… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

0
13
0

Year Published

2013
2013
2023
2023

Publication Types

Select...
8
1

Relationship

2
7

Authors

Journals

citations
Cited by 14 publications
(13 citation statements)
references
References 48 publications
0
13
0
Order By: Relevance
“…Phenotypic maturation in vivo was shown to not carry the immune privileges of therapeutic FPCs in rodent models (Hausherr et al, 2017). Chemical functionalization (e.g., click chemistry, bioorthogonal chemical reactions, covalent binding) of therapeutic cell surfaces allows optimal conjugation with bioengineered scaffolds, while maintaining and optimizing cellular viability, adhesion, persistence, and function (Borcard et al, 2011(Borcard et al, , 2012Comas et al, 2012;Krauss Juillerat et al, 2012). Optimal mechanical properties and efficient vascularization capacity of implanted constructs are essential, while biodegradable hydrogels may enable local cell maintenance (Tenorio et al, 2011;Amini et al, 2012).…”
Section: Bone Fpc Modulation and Drug Deliverymentioning
confidence: 99%
“…Phenotypic maturation in vivo was shown to not carry the immune privileges of therapeutic FPCs in rodent models (Hausherr et al, 2017). Chemical functionalization (e.g., click chemistry, bioorthogonal chemical reactions, covalent binding) of therapeutic cell surfaces allows optimal conjugation with bioengineered scaffolds, while maintaining and optimizing cellular viability, adhesion, persistence, and function (Borcard et al, 2011(Borcard et al, , 2012Comas et al, 2012;Krauss Juillerat et al, 2012). Optimal mechanical properties and efficient vascularization capacity of implanted constructs are essential, while biodegradable hydrogels may enable local cell maintenance (Tenorio et al, 2011;Amini et al, 2012).…”
Section: Bone Fpc Modulation and Drug Deliverymentioning
confidence: 99%
“…Indeed, azides, alkynes, thiols and methacryloyls have been successfully incorporated into cell surface glycans, [44][45][46][47] amino acids 15,28,48,49 and lipids, 50 with applications that include the selective killing of cells, 51 drug conjugation, 46 cell-surface click gelation 52 and artificial adhesion to 2D or 3D substrates. 15,45 Metabolic labeling and bio-orthogonal strategies still suffer from limitations associated with tightly regulated biosynthetic pathways (more of an issue for amino acids than glycans), interference from specific metabolic pathways (a particular issue with ketone labeling), cytotoxicity arising from certain mediators (such as copper ions in certain azide-alkyne reactions) and the necessity to include a compatible, ''clickable'' functional group on the secondary reactive species. 53 Most of these issues can be overcome with careful experimental design, and metabolic labeling coupled with bio-orthogonal bioconjugate chemistry remains an elegant approach to cell Metabolic labeling can be used to present reactive groups that can bind a secondary species (yellow).…”
Section: Covalent Cell Surface Chemistry and Bio-orthogonal Labelingmentioning
confidence: 99%
“…Hydroxyapatite [HAP, Ca 10 (PO 4 ) 6 (OH) 2 ], β ‐tricalcium phosphate [ β ‐TCP, β ‐Ca 3 (PO 4 ) 2 ], and bioglass are scaled as bioactive while the major bioinert components are zirconia [ZrO 2 ] and alumina [Al 2 O 3 ] . Recent years demonstrated a major shift toward the application of bioceramics in the treatment of osteosarcoma . Imparting magnetic feature in bioceramics, commonly termed as magnetic bioceramics is recently established as an important topic.…”
Section: Introductionmentioning
confidence: 99%
“…[1][2][3] Recent years demonstrated a major shift toward the application of bioceramics in the treatment of osteosarcoma. 4 Imparting magnetic feature in bioceramics, commonly termed as magnetic bioceramics is recently established as an important topic. Handful of investigations have been already reported in this research area that aims to deliver dual features of magnetic property and appropriate biocompatibility to treat bone tumors.…”
Section: Introductionmentioning
confidence: 99%